T-cell tolerant fraction as a predictor of immune-related adverse events

Background Immune checkpoint inhibitor (ICI) therapies may cause unpredictable and potentially severe autoimmune toxicities termed immune-related adverse events (irAEs). Because T cells mediate ICI effects, T cell profiling may provide insight into the risk of irAEs. Here we evaluate a novel metric—...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	Yang Xie, Shaheen Khan, Prithvi Raj, Edward K Wakeland, Mitchell S von Itzstein, Farjana Fattah, Jason Y Park, David Hsiehchen, Jared Ostmeyer, David E Gerber, Mary Gwin, Rodrigo Catalan
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	BMJ Publishing Group 2023-08-01
श्रृंखला:	Journal for ImmunoTherapy of Cancer
ऑनलाइन पहुंच:	https://jitc.bmj.com/content/11/8/e006437.full
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!